ISIS-SMNRx is a new drug being developed by ISIS Pharmaceuticals with the goal of reducing the severity of spinal muscular atrophy (SMA) in infants. Classified as an antisense…
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
Spinal muscular atrophy (SMA) is the result of being born without – or with a defective version of – the survival motor neuron 1 (SMN1) gene. This gene…
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
TXA-709 is a new type of antibiotic being developed by TAXIS Pharmaceuticals. The antibiotic specifically targets variants of the MRSA bacteria. TXA-709, a FtsZ-targeting benzamide prodrug, should be…
Researchers from the British Columbia Cancer Agency and UBC Vancouver Coastal Health have found a protein present in the malaria parasite that easily bonds with a sugar molecule…